Drawing for GENESIG

USPTO serial 90249594

GENESIG

Reviewed by CopyMark Law Group

Reg. 6874875Status 700Registered
Filing date
Status date
Registration date
Oct 18, 2022
Examiner
WINTER, MELISSA S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENESIG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Liebowitz

Rebecca Liebowitz VENABLE LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for scientific purposes, namely, for use in performing nucleic acid polymerase chain reactions for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification, and bio-threat detection; chemical preparations for use in polymerase chain reactions for research and analysis purposes, not in the medical or veterinary fields; chemical preparations for scientific purposes, namely, for use in the extraction of DNA and RNA from cells; diagnostic preparations for scientific use, namely, primers, reagents and chemical preparations for use in polymerase chain reactions for laboratory purposes; chemical reagents for use in RNA and DNA analysis other than for medical or veterinary purposes; kits comprised of reagents, vials and printed instructions for the preparation of samples for polymerase chain reaction testing for laboratory and research purposesACTIVE—
005Chemical reagents for use in polymerase chain reactions for medical and veterinary purposes; chemical reagents for medical and veterinary use, namely, for use in performing polymerase chain reactions for pathogen detection, detection of genetically modified organisms, species identification, and veterinary and medical disease detection; diagnostic preparations, namely, chemicals for use in the extraction of DNA and RNA from cells for medical and veterinary purposes; diagnostic preparations, namely, primers, reagents and chemical preparations for use in polymerase chain reactions for medical and veterinary purposes; chemical reagents for use in RNA and DNA analysis for medical or veterinary purposes; kits comprised of reagents, vials and printed instructions for the preparation of samples for polymerase chain reaction testing for medical and veterinary purposesACTIVE—
009Apparatus for conducting polymerase chain reactions; apparatus for conducting quantitative or real-time polymerase chain reactions; medical laboratory research instruments for DNA analysis, namely, qPCR machines; apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; apparatus for use in extracting RNA and DNA; sample containers, vials, pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for testing; racks for holding sample pipettes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, petri dishes, pipettes and vials; all the foregoing being for laboratory and research purposesACTIVE—
010Diagnostic apparatus for conducting polymerase chain reactions; diagnostic apparatus for conducting quantitative or real-time polymerase chain reactions; diagnostic apparatus, namely, qPCR machines; diagnostic apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; diagnostic apparatus for use in extracting RNA and DNA; sample containers, vials, dropping pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for diagnostic testing; diagnostic kits consisting primarily of vials, instructions and reagents for use in the preparation of samples for polymerase chain reaction testing; racks for holding sample tubes and vials during diagnostic testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, dropping pipettes, medical specimen bags, petri dishes and vials for holding body tissue samples for testing purposes; all the foregoing being for medical or veterinary purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 18, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 18, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 2, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 2, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 29, 2022OTHECASE RETURNED TO EXAMINATION—
Jun 29, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 28, 2022ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Jun 28, 2022PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Jun 27, 2022APETASSIGNED TO PETITION STAFF—
Jun 3, 2022TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Feb 1, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 29, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Oct 29, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 29, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 29, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 20, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2021DOCKASSIGNED TO EXAMINER—
Nov 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance